PE and VC firm Frazier Healthcare Partners added Amanda Bosse to the firm’s Growth Buyout team as an executive in residence. Bosse, who has 20 years of industry experience, will work alongside the firm to develop and execute investment strategies focused on differentiated outsourced pharmaceutical contract manufacturing and scientific services enabling advanced therapies. She will focus on the sourcing, diligence, and leadership of a new platform that enables the next generation of life sciences products and personalized medicine. Read more.
Related Posts
agilon health Prices Secondary Offering of 17M Shares
The offering price is $30 per share. The company will not receive any proceeds from the secondary offering.
September 10, 2021
M&A Exec Rob Scott Joins Argosy Healthcare Partners
Scott was most recently a Vice President at Baker Tilley Capital, where he executed M&A transactions in the lower middle market, Argosy said in a press release.
September 7, 2021
Where Google, One of the Most Active Health Care Investors, Puts its Capital
Since 2020, the tech giant and its affiliated venture funds have led 25 health-related rounds collectively valued at just over $1.6 billion.
December 20, 2021
J2 Ventures Gathers $52M Fund for Healthcare, Tech Investments
Boston-based J2 formed in 2020 and initially raised individual pools of capital to fund healthcare and technology startups.
December 23, 2021